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Clinics and pathology 
Disease 
T cell acute lymphocytic leukaemia (T-ALL). 
Clinics 
Yet poorly known: only 1 case: a young adult male 
patient with high WBC (common features in T-
ALL); bone marrow transplantation; complete 
remission: 43 mths +. 






Complex alternate splicing. 
Protein 
Contains a basic Helix-Loop-Helix (DNA binding) 
domain; forms heterodimers; transcription factor; 
role in haematopoietic cell differentiation. 
Yet unknown gene 
Location 
5q31 




Breakpoint on TAL1 was found 10 kb upstream the 
gene, as was found in the cases of t(1;3)(p32;p21), 
while it is more 3', within the gene, in the 
t(1;14)(p32;q11) and in TAL1 deletions. 
Fusion protein 
Expression / Localisation 
High nuclear expression. 
References 
François S, Delabesse E, Baranger L, Dautel M, Foussard 
C, Boasson M, Blanchet O, Bernard O, Macintyre EA, Ifrah 
N. Deregulated expression of the TAL1 gene by 
t(1;5)(p32;31) in patient with T-cell acute lymphoblastic 
leukemia. Genes Chromosomes Cancer. 1998 
Sep;23(1):36-43 
This article should be referenced as such: 
Huret JL. t(1;5)(p32;q31). Atlas Genet Cytogenet Oncol 
Haematol. 1999; 3(1):21. 
 
